Travel Vaccines Market Growth, Demand and Challenges of the Key Industry Players 2023-2028

Report DescriptionAbout IMARC Group

The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

Global Travel Vaccines Market Research Report:

The latest report by IMARC, titled “ Travel Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 20232028

” finds that the global travel vaccines market reached a value of US$ 3.6 Billion in 2022. Travel vaccines, also known as travel immunizations, are shots that travelers receive before visiting certain parts of the world where there is a high risk of developing certain diseases. These vaccines introduce the diseasecausing microbes into the bloodstream to help the human body produce antibodies that will fight off the same if the person is exposed to the disease again. These shots must be taken at least 4 to 6 weeks before traveling, as it gives enough time for the immunization to start working efficiently.

Request Free Sample Report: https://www.imarcgroup.com/travel-vaccines-market/requestsample

Report Description Report Description and Highlights

Global Travel Vaccines Market Trends :

The market is primarily driven by the rising occurrence of infectious and travel-related diseases such as diphtheria, Japanese encephalitis, meningitis, and yellow fever. In addition, there has been significant growth in international tourism due to rapid globalization and reduced international airfares. As a result, the demand for travel vaccines has witnessed substantial growth across the globe. Besides this, combination vaccines are gaining popularity among travelers as they protect against multiple diseases and reduce the number of vaccines required, thereby contributing to the market growth. Moreover, travel vaccines have become an essential requirement in an international travelers list as governments of numerous countries have mandated that travelers should be vaccinated before visiting diseaseprone regions. For instance, the National Health Service (NHS) is providing several free travel vaccines for diseases, such as cholera, polio, typhoid and hepatitis A, in the United Kingdom to reduce the risk of these diseases being spread across the country. On account of these factors, IMARC Group expects the market to grow at a CAGR of 10.95% during 2023-2028.

Looking forward, the market value is projected to reach a strong growth during the forecast period (2023-2028).

Report Description Report Description and Highlights

Market Summary:

Breakup by Composition:

• Mono Vaccines

• Combination Vaccines

Breakup by Disease:

• Hepatitis A

• DPT

• Yellow Fever

• Typhoid

• Hepatitis B

• Measles and Mumps

• Rabies

• Meningococcal

• Varicella

• Japanese Encephalitis

• Others

Report Description Report Description and Highlights

Regional Insights:

• Asia Pacific

• North America

• Europe

• Middle East and Africa

• Latin America

Note: We are updating our reports, If you want latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report.

Competitive Landscape with Key Players:

Sanofi Pasteur

Merck & Co.Inc.

Novartis AG

Pfizer Inc.

ALK-Abelló A/S

Bavarian Nordic A/S

Crucell (Subsidiary of Johnson & Johnson)

CSL Limited

AstraZeneca PLC

Altimmune Inc.

Abbott Laboratories

• Hoffmann-La Roche Inc.

View Full Report with TOC & List of Figure: https://www.imarcgroup.com/travel-vaccines-market

A partial List of our Clients

Partial List of Clients

We are the trusted business partners to the world's leading corporates, governments, and institutions

A partial List of our Clients

Partial List of Clients

We are the trusted business partners to the world's leading corporates, governments, and institutions

Report Description Report Description and Highlights

© 2019 IMARC All Rights Reserved

This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).

Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.

IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.